Medical Conditions

Morphea (Localized Scleroderma) in Children

Medically reviewed by Dr. Michael Okonkwo, MD, FAAP · Board-Certified Neonatologist

Content reviewed against published AAP, ACR, NIH guidelines

Editorial policy

Last reviewed:

If your baby has been diagnosed with or you suspect morphea (localized scleroderma) in children, here is what the evidence says.

The short answer

Morphea, also called localized scleroderma, is an autoimmune condition that causes hardened, thickened patches of skin. In children, the most common form is linear morphea, where a band of hardened skin develops along a limb or on the face/scalp. Unlike systemic scleroderma (a different disease that affects internal organs), morphea is limited to the skin and underlying tissues. However, linear morphea in children can extend deeper to affect muscle, bone, and joints, potentially affecting limb growth or causing facial asymmetry. Early treatment with methotrexate and sometimes corticosteroids can halt disease progression and prevent growth-related complications.

Key takeaways

  • Morphea, also called localized scleroderma, is an autoimmune condition that causes hardened, thickened patches of skin. In children, the most common form is linear morphea, where a band of hardened skin develops along a limb or on the face/scalp. Unlike systemic scleroderma (a different disease that affects internal organs), morphea is limited to the skin and underlying tissues. However, linear morphea in children can extend deeper to affect muscle, bone, and joints, potentially affecting limb growth or causing facial asymmetry. Early treatment with methotrexate and sometimes corticosteroids can halt disease progression and prevent growth-related complications.
  • Usually normal when: A small, stable, soft discoloration on the skin that is not getting harder or larger — many birthmarks and benign skin conditions can look similar initially
  • Call your doctor if: Your child has rapidly spreading or deepening linear morphea crossing a major joint, causing restriction of movement — aggressive treatment is needed to prevent permanent contracture and growth impairment
  • Varies by age — see the age-by-age breakdown below
Fever itself is not an illness — rather, it is a sign or symptom that the body is fighting an infection. Fever stimulates certain defenses, such as the white blood cells, which attack and destroy invading bacteria.
Fever and Your Child, American Academy of Pediatrics (AAP)

This is one of the most common questions parents ask. Searching for answers means you care.

What Parents Should Know

According to AAP, ACR, NIH guidelines, morphea, also called localized scleroderma, is an autoimmune condition that causes hardened, thickened patches of skin. In children, the most common form is linear morphea, where a band of hardened skin develops along a limb or on the face/scalp. Unlike systemic scleroderma (a different disease that affects internal organs), morphea is limited to the skin and underlying tissues. However, linear morphea in children can extend deeper to affect muscle, bone, and joints, potentially affecting limb growth or causing facial asymmetry. Early treatment with methotrexate and sometimes corticosteroids can halt disease progression and prevent growth-related complications. At 0-6 months, morphea is very rare in infants. Skin changes in a baby this young — such as hardened, discolored, or unusually textured patches — are more commonly due to other conditions like infantile hemangioma, dermal melanocytosis, or congenital skin disorders. If you notice an unusual skin patch on your baby that feels firm or is changing in size, have your pediatrician evaluate it. A biopsy may be needed if the diagnosis is uncertain. It is generally considered normal when a small, stable, soft discoloration on the skin that is not getting harder or larger — many birthmarks and benign skin conditions can look similar initially. However, you should contact your pediatrician promptly if your child has rapidly spreading or deepening linear morphea crossing a major joint, causing restriction of movement — aggressive treatment is needed to prevent permanent contracture and growth impairment.

Sources: [1], [2], [3]

Normal vs. Concerning

Usually Normal
Worth Discussing
A small, stable, soft discoloration on the skin that is not getting harder or larger — many birthmarks and benign skin conditions can look similar initially
Your child has rapidly spreading or deepening linear morphea crossing a major joint, causing restriction of movement — aggressive treatment is needed to prevent permanent contracture and growth impairment
An old, inactive morphea patch that is no longer changing — once morphea becomes inactive, the hardened area gradually softens over months to years
Your child has en coup de sabre morphea on the face with new neurological symptoms (seizures, headaches, vision changes) — rarely, linear morphea on the face can extend to involve the underlying brain, requiring urgent neurology evaluation
Your child's morphea is being treated and the lilac ring (purple border indicating active disease) has resolved
Your child has a new skin patch that is becoming progressively harder, tighter, or more discolored
Your child with morphea has full range of motion in all joints and no limb length difference
Your child has a band of hardened skin along a limb, especially if it crosses a joint or seems to be affecting movement

By Age

What to expect by age

0-6 months

Morphea is very rare in infants. Skin changes in a baby this young — such as hardened, discolored, or unusually textured patches — are more commonly due to other conditions like infantile hemangioma, dermal melanocytosis, or congenital skin disorders. If you notice an unusual skin patch on your baby that feels firm or is changing in size, have your pediatrician evaluate it. A biopsy may be needed if the diagnosis is uncertain.

6-12 months

While uncommon, morphea can occasionally begin in the first year. Early morphea may appear as a reddish or purplish patch that gradually becomes firmer and develops a waxy, ivory-colored center with a purple border (the "lilac ring," which indicates active disease). If you notice a skin patch that is becoming progressively harder or is restricting your baby's movement, seek evaluation by a pediatric dermatologist.

1-3 years

Morphea becomes more commonly diagnosed in this age group. Linear morphea — a band of hardened skin running along an arm, leg, or across the face — is the most concerning subtype in children because it can extend into deeper tissues, affecting muscle and bone growth. If linear morphea crosses a joint, it can cause contracture (limited range of motion). On the face and scalp, a specific pattern called "en coup de sabre" creates a linear indentation that can affect underlying bone and, rarely, the brain. Early treatment is important to prevent these complications.

3+ years

The peak onset of childhood morphea is between ages 2 and 14. Linear morphea is the most common subtype (about 65% of childhood morphea). Treatment typically involves methotrexate (a low-dose immunosuppressant taken weekly) with an initial course of oral or IV corticosteroids to halt active disease quickly. Physical therapy is important if joints are affected. Most morphea eventually becomes inactive, but the skin changes and any growth differences may persist. Importantly, morphea does NOT progress to systemic sclerosis — these are distinct diseases. Children with morphea need monitoring for limb length discrepancy and functional limitations.

What to Tell Your Pediatrician

  • Describe when you first noticed morphea (localized scleroderma) in children and how it has changed over time.
  • Note your baby's current age and which age-specific patterns you are seeing.
  • Mention if your child has a new skin patch that is becoming progressively harder, tighter, or more discolored.
  • Mention if your child has a band of hardened skin along a limb, especially if it crosses a joint or seems to be affecting movement.
  • Let your doctor know if you have noticed any related concerns, such as changes in feeding, sleep, or movement patterns.
  • Bring a list of any questions or observations you want to discuss at the appointment.

What Should You Do?

When to take action

Probably normal when...
  • A small, stable, soft discoloration on the skin that is not getting harder or larger — many birthmarks and benign skin conditions can look similar initially
  • An old, inactive morphea patch that is no longer changing — once morphea becomes inactive, the hardened area gradually softens over months to years
  • Your child's morphea is being treated and the lilac ring (purple border indicating active disease) has resolved
  • Your child with morphea has full range of motion in all joints and no limb length difference
Mention at your next visit when...
  • Your child has a new skin patch that is becoming progressively harder, tighter, or more discolored
  • Your child has a band of hardened skin along a limb, especially if it crosses a joint or seems to be affecting movement
  • Your child has a linear indentation on the forehead or scalp (en coup de sabre pattern)
  • Your child with known morphea seems to be developing new active patches or a limb length difference
Act now when...
  • Your child has rapidly spreading or deepening linear morphea crossing a major joint, causing restriction of movement — aggressive treatment is needed to prevent permanent contracture and growth impairment
  • Your child has en coup de sabre morphea on the face with new neurological symptoms (seizures, headaches, vision changes) — rarely, linear morphea on the face can extend to involve the underlying brain, requiring urgent neurology evaluation

What You Can Do at Home

  • Keep track of when you notice morphea (localized scleroderma) in children — noting the time of day, duration, and any triggers can help your pediatrician.
  • Remember that a small, stable, soft discoloration on the skin that is not getting harder or larger — many birthmarks and benign skin conditions can look similar initially — this is generally within the range of normal.
  • At 0-6 months, focus on observation rather than intervention unless your pediatrician advises otherwise.
  • Follow any care instructions from your pediatrician. Keep a written log of symptoms to bring to appointments.
  • While monitoring at home, seek immediate care if your child has rapidly spreading or deepening linear morphea crossing a major joint, causing restriction of movement — aggressive treatment is needed to prevent permanent contracture and growth impairment.

Signs of Autoimmune Conditions in Babies

Autoimmune conditions occur when the immune system mistakenly attacks the body's own tissues. While less common in babies than in older children and adults, they can occur. Signs depend on the affected organ system but may include unexplained rash, joint swelling, persistent fevers, blood count abnormalities, or organ dysfunction. Some autoimmune conditions in babies (like neonatal lupus) are caused by maternal antibodies crossing the placenta. Early diagnosis and treatment by a pediatric specialist improve outcomes.

Juvenile Idiopathic Arthritis (JIA) in Children

Juvenile idiopathic arthritis (JIA) is the most common chronic rheumatic disease of childhood, affecting about 1 in 1,000 children. It is defined as joint inflammation (arthritis) lasting at least 6 weeks in a child under 16 years with no other identifiable cause. JIA is an autoimmune condition — the immune system mistakenly attacks the joint lining (synovium). Symptoms include joint swelling, stiffness (especially in the morning or after rest), pain, and sometimes limping. There are several subtypes, with oligoarticular (4 or fewer joints) being the most common. With modern treatments, most children with JIA can achieve remission and live active, normal lives.

Signs of Lupus (SLE) in Children

Systemic lupus erythematosus (SLE or lupus) is a chronic autoimmune disease in which the immune system attacks healthy tissue throughout the body. Childhood-onset lupus (diagnosed before age 18) accounts for about 15-20% of all lupus cases and tends to be more severe than adult-onset lupus, with kidney involvement occurring in up to 80% of pediatric cases. Common symptoms include a butterfly-shaped rash across the cheeks and nose, joint pain and swelling, extreme fatigue, fever, mouth sores, sun sensitivity, and hair loss. While lupus is a lifelong condition, modern treatments can effectively control the disease and prevent organ damage.

Frequently asked questions

Is morphea (localized scleroderma) in children normal?
Morphea, also called localized scleroderma, is an autoimmune condition that causes hardened, thickened patches of skin. In children, the most common form is linear morphea, where a band of hardened skin develops along a limb or on the face/scalp. Unlike systemic scleroderma (a different disease that affects internal organs), morphea is limited to the skin and underlying tissues. However, linear morphea in children can extend deeper to affect muscle, bone, and joints, potentially affecting limb growth or causing facial asymmetry. Early treatment with methotrexate and sometimes corticosteroids can halt disease progression and prevent growth-related complications.
When should I call the doctor about morphea (localized scleroderma) in children?
Your child has rapidly spreading or deepening linear morphea crossing a major joint, causing restriction of movement — aggressive treatment is needed to prevent permanent contracture and growth impairment Your child has en coup de sabre morphea on the face with new neurological symptoms (seizures, headaches, vision changes) — rarely, linear morphea on the face can extend to involve the underlying brain, requiring urgent neurology evaluation
When is morphea (localized scleroderma) in children normal?
A small, stable, soft discoloration on the skin that is not getting harder or larger — many birthmarks and benign skin conditions can look similar initially An old, inactive morphea patch that is no longer changing — once morphea becomes inactive, the hardened area gradually softens over months to years Your child's morphea is being treated and the lilac ring (purple border indicating active disease) has resolved
What causes morphea (localized scleroderma) in children?
Morphea, also called localized scleroderma, is an autoimmune condition that causes hardened, thickened patches of skin. In children, the most common form is linear morphea, where a band of hardened skin develops along a limb or on the face/scalp. Unlike systemic scleroderma (a different disease that affects internal organs), morphea is limited to the skin and underlying tissues. However, linear morphea in children can extend deeper to affect muscle, bone, and joints, potentially affecting limb growth or causing facial asymmetry. Early treatment with methotrexate and sometimes corticosteroids can halt disease progression and prevent growth-related complications. Common explanations include: A small, stable, soft discoloration on the skin that is not getting harder or larger — many birthmarks and benign skin conditions can look similar initially. An old, inactive morphea patch that is no longer changing — once morphea becomes inactive, the hardened area gradually softens over months to years.
What should I mention to my pediatrician about morphea (localized scleroderma) in children?
You should mention morphea (localized scleroderma) in children at your next visit if: Your child has a new skin patch that is becoming progressively harder, tighter, or more discolored. Your child has a band of hardened skin along a limb, especially if it crosses a joint or seems to be affecting movement. Your child has a linear indentation on the forehead or scalp (en coup de sabre pattern).
Is morphea (localized scleroderma) in children normal at 0-6 months?
Morphea is very rare in infants. Skin changes in a baby this young — such as hardened, discolored, or unusually textured patches — are more commonly due to other conditions like infantile hemangioma, dermal melanocytosis, or congenital skin disorders. If you notice an unusual skin patch on your baby that feels firm or is changing in size, have your pediatrician evaluate it. A biopsy may be needed if the diagnosis is uncertain.
Is morphea (localized scleroderma) in children normal at 6-12 months?
While uncommon, morphea can occasionally begin in the first year. Early morphea may appear as a reddish or purplish patch that gradually becomes firmer and develops a waxy, ivory-colored center with a purple border (the "lilac ring," which indicates active disease). If you notice a skin patch that is becoming progressively harder or is restricting your baby's movement, seek evaluation by a pediatric dermatologist.
Should I go to the ER for morphea (localized scleroderma) in children?
Seek emergency care if your child has rapidly spreading or deepening linear morphea crossing a major joint, causing restriction of movement — aggressive treatment is needed to prevent permanent contracture and growth impairment, or if your child has en coup de sabre morphea on the face with new neurological symptoms (seizures, headaches, vision changes) — rarely, linear morphea on the face can extend to involve the underlying brain, requiring urgent neurology evaluation. When in doubt, call your pediatrician's after-hours line for guidance.
Does morphea (localized scleroderma) in children go away on its own?
In many cases, morphea (localized scleroderma) in children resolves on its own, especially when a small, stable, soft discoloration on the skin that is not getting harder or larger — many birthmarks and benign skin conditions can look similar initially. By 3+ years, the peak onset of childhood morphea is between ages 2 and 14. Linear morphea is the most common subtype (about 65% of childhood morphea). Treatment typically involves methotrexate (a low-dose immunosuppressant taken weekly) with an initial course of oral or IV corticosteroids to halt active disease quickly. Physical therapy is important if joints are affected. Most morphea eventually becomes inactive, but the skin changes and any growth differences may persist. Importantly, morphea does NOT progress to systemic sclerosis — these are distinct diseases. Children with morphea need monitoring for limb length discrepancy and functional limitations.

References

  1. [1]American Academy of Pediatrics. Morphea and Localized Scleroderma in Children. Pediatric Dermatology, 2019. AAP
  2. [2]American College of Rheumatology. Localized Scleroderma. ACR, 2023. ACR
  3. [3]National Institute of Arthritis and Musculoskeletal and Skin Diseases. Scleroderma. NIAMS, 2023. NIH

Doctor Visit Checklist

Bring this checklist to your next pediatrician visit to discuss Morphea (Localized Scleroderma) in Children.

Things to mention

  • Describe when you first noticed morphea (localized scleroderma) in children and how it has changed over time.
  • Note your baby's current age and which age-specific patterns you are seeing.
  • Mention if your child has a new skin patch that is becoming progressively harder, tighter, or more discolored.
  • Mention if your child has a band of hardened skin along a limb, especially if it crosses a joint or seems to be affecting movement.
  • Let your doctor know if you have noticed any related concerns, such as changes in feeding, sleep, or movement patterns.
  • Bring a list of any questions or observations you want to discuss at the appointment.

Observations to share

  • Your child has a new skin patch that is becoming progressively harder, tighter, or more discolored
  • Your child has a band of hardened skin along a limb, especially if it crosses a joint or seems to be affecting movement
  • Your child has a linear indentation on the forehead or scalp (en coup de sabre pattern)

Urgent signs to report immediately

  • Your child has rapidly spreading or deepening linear morphea crossing a major joint, causing restriction of movement — aggressive treatment is needed to prevent permanent contracture and growth impairment
  • Your child has en coup de sabre morphea on the face with new neurological symptoms (seizures, headaches, vision changes) — rarely, linear morphea on the face can extend to involve the underlying brain, requiring urgent neurology evaluation

My notes

From ismybabyalright.com — free, evidence-based baby health guides

All content follows our editorial policy and is reviewed against published clinical guidelines.

2,705 evidence-based guides6 authoritative medical sources5 medical advisory board members

Bottom line

Most cases of morphea (localized scleroderma) in children are normal. Talk to your pediatrician if your child has rapidly spreading or deepening linear morphea crossing a major joint, causing restriction of movement — aggressive treatment is needed to prevent permanent contracture and growth impairment.

Trust your instincts. If something feels wrong, reach out to your pediatrician. Worrying about your baby means you care — that is a good thing.

Share:FacebookX

Was this page helpful?

Signs of Autoimmune Conditions in Babies

Autoimmune conditions occur when the immune system mistakenly attacks the body's own tissues. While less common in babies than in older children and adults, they can occur. Signs depend on the affected organ system but may include unexplained rash, joint swelling, persistent fevers, blood count abnormalities, or organ dysfunction. Some autoimmune conditions in babies (like neonatal lupus) are caused by maternal antibodies crossing the placenta. Early diagnosis and treatment by a pediatric specialist improve outcomes.

Juvenile Idiopathic Arthritis (JIA) in Children

Juvenile idiopathic arthritis (JIA) is the most common chronic rheumatic disease of childhood, affecting about 1 in 1,000 children. It is defined as joint inflammation (arthritis) lasting at least 6 weeks in a child under 16 years with no other identifiable cause. JIA is an autoimmune condition — the immune system mistakenly attacks the joint lining (synovium). Symptoms include joint swelling, stiffness (especially in the morning or after rest), pain, and sometimes limping. There are several subtypes, with oligoarticular (4 or fewer joints) being the most common. With modern treatments, most children with JIA can achieve remission and live active, normal lives.

Signs of Lupus (SLE) in Children

Systemic lupus erythematosus (SLE or lupus) is a chronic autoimmune disease in which the immune system attacks healthy tissue throughout the body. Childhood-onset lupus (diagnosed before age 18) accounts for about 15-20% of all lupus cases and tends to be more severe than adult-onset lupus, with kidney involvement occurring in up to 80% of pediatric cases. Common symptoms include a butterfly-shaped rash across the cheeks and nose, joint pain and swelling, extreme fatigue, fever, mouth sores, sun sensitivity, and hair loss. While lupus is a lifelong condition, modern treatments can effectively control the disease and prevent organ damage.

My Baby's Head Shape Looks Abnormal

Many babies develop temporary head shape irregularities that are completely normal. A cone-shaped head from vaginal delivery reshapes within days. Mild positional flattening (plagiocephaly) from sleeping on the back is very common and usually improves with repositioning and tummy time. However, head shape changes involving ridges, a persistently bulging fontanelle, or rapid head growth changes should be evaluated to rule out craniosynostosis.

Achondroplasia (Dwarfism) in Babies

Achondroplasia is the most common form of short-limbed dwarfism, affecting about 1 in 15,000 to 40,000 births. It is caused by a mutation in the FGFR3 gene and is usually apparent at birth with characteristic features including short limbs, a larger head, and a prominent forehead. Intelligence is normal. With monitoring for specific complications and supportive care, children with achondroplasia lead full, active, and independent lives.

Adenoid Hypertrophy and Breathing

Adenoids are lymphoid tissue located behind the nose that help fight infection in young children. When adenoids become enlarged (adenoid hypertrophy), they can block the nasal airway, causing chronic mouth breathing, snoring, nasal speech, and sleep-disordered breathing. Enlarged adenoids are most common between ages 2-7 and are a leading cause of obstructive sleep apnea in young children. Treatment ranges from watchful waiting and nasal steroids to surgical removal (adenoidectomy) if breathing or sleep is significantly affected.